# US 2001/0018533 A1 · Process for producing 13-cis retinoic acid

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0018533 A1
- Document ID: US20010018533A1
- Status: Published application
- Kind: A1
- Application number: 09/484,675
- Filed: 2000-01-18
- Published: 2001-08-30
- Earliest claimed: 1998-03-25
- Inventors: Xiu C. Wang; Ashok V. Bhatia; Azad Hossain; Timothy B. Towne
- Web page: https://patentgrep.com/patent/US20010018533A1

## CPC

- C07C 403/20: having side-chains substituted by carboxyl groups {or halides, anhydrides, or (thio)esters thereof}
- C07B 2200/09: Geometrical isomers
- C07C 2601/16: the ring being unsaturated
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

The process of the present invention relates to a process for producing 1 3-cis retinoic acid. The process of the present invention involves reacting a Wittig salt in a solvent with a butenolide in the presence of a weak base and optionally, a Lewis acid.

## Claims

### Claim 1

A process for producing a compound of formula IV: 6
comprising the steps of:
a). reacting in a solvent in the presence of a weak base, a butenolide of the formula II: 7
with a salt of the formula: 8
where R1, R2 and R3 are independently selected from aryl or dialkylamino, R4 and R5 are independently selected from hydrogen, loweralkyl, alkoxy, cycloalkyl, aryl, or heterocyclic, and X is selected from halogen or hydrogen sulfate, to form a reaction mixture; and
b). recovering the compound from the reaction mixture.

### Claim 2 (depends on 1)

The process of claim 1 wherein said solvent is a polar aprotic solvent.

### Claim 3 (depends on 2)

The process of claim 2 wherein the polar aprotic solvent is selected from the group consisting of: methylene chloride, chloroform, acetonitrile, tetrahydrofuran, 1,4-dioxane, N,N′-dimethylformamide, 1-methyl-2-pyrrolidinone, 1,3-dimethyl-2-imidazolidinone, N,N′-dimethylacetamide, and mixtures thereof.

### Claim 4 (depends on 2)

The process of claim 2 wherein solvent is a mixture of a polar aprotic solvent and a non-polar solvent.

### Claim 5 (depends on 4)

The process of claim 4 wherein the non-polar solvent is toluene, chlorobenzene or alkanes.

### Claim 6 (depends on 1)

The process of claim 1 wherein the weak base is a tertiary amine, carbonate, bicarbonate or an acetate.

### Claim 7 (depends on 6)

The process of claim 6 wherein the weak base is selected from tertiary amines, sodium acetate, potassium acetate, cesium acetate, and sodium bicarbonate.

### Claim 8 (depends on 1)

The process of claim 1 wherein said compound is 13-cis retinoic acid.

### Claim 9 (depends on 1)

The process of claim 1 wherein the ratio of weak base to butenolide is from about 2:1 to about 10:1.

### Claim 10 (depends on 1)

The process of claim 1 wherein the ratio of butenolide to the Wittig salt is from about 1:1 to about 10:1.

### Claim 11

A process for producing a compound of formula IV: 9
the process comprising the steps of reacting in a solvent in the presence of a weak base and a Lewis acid, a butenolide of the formula II: 10
wherein R1, R2 and R3 are independently selected from aryl or dialkylamino, and R4 and R5 are independently selected from hydrogen, loweralkyl, alkoxy, cycloalkyl, aryl, or heterocyclic, with a salt of the formula I: 11

### Claim 12 (depends on 11)

The process of claim 11 wherein the solvent is a polar aprotic solvent or a mixture of a polar aprotic solvent and non-polar solvent.

### Claim 13 (depends on 11)

The process of claim 11 wherein the Lewis acid is magnesium triflate, magnesium bromide, magnesium trifluoracetate, magnesium chloride, magnesium iodide or magnesium fluoride

### Claim 14 (depends on 11)

The process of claim 11 wherein the molar ratio of Lewis acid to the Wittig salt is from about 1:1 to about 3:1.

### Claim 15 (depends on 11)

The process of claim 11 wherein the ratio of weak base to butenolide is from about 2:1 to about 10:1.

### Claim 16 (depends on 11)

The process of claim 11 wherein the ratio of butenolide to the Wittig salt is from about 1:1 to about 10:1.

### Claim 17 (depends on 11)

The process of claim 11 wherein said compound is 13-cis retinoic acid.

### Claim 18 (depends on 11)

The process of claim 11 wherein the weak based is a tertiary amine.

### Claim 19 (depends on 18)

The process of claim 18 wherein said tertiary amine is selected from triethylamine, diisopropylethylamine, and N-ethylpiperidine.
